Search all medical codes

Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use

CPT4 code

Name of the Procedure:

Measles, Mumps, Rubella, and Varicella Vaccine (MMRV), live, for subcutaneous use

Summary

The MMRV vaccine is an injection given under the skin to protect against four serious viral infections: measles, mumps, rubella (German measles), and varicella (chickenpox).

Purpose

The MMRV vaccine is designed to prevent infections caused by the measles, mumps, rubella, and varicella viruses. The goal is to provide immunity, thereby reducing the risk of these illnesses and their potential complications.

Indications

The vaccine is indicated for:

  • Children aged 1 year and older.
  • Older individuals without documented immunity to these diseases.
  • Specific criteria include no previous vaccinations against these viruses or no history of having had these infections.

Preparation

  • Patients or parents should discuss the child’s medical history, including allergies and any current medications, with the healthcare provider.
  • The provider will ensure the patient is not currently ill with a fever or other acute infection.

Procedure Description

  1. The healthcare provider will clean the injection site, typically the upper arm, with an antiseptic.
  2. A sterile syringe and needle are used to administer the vaccine subcutaneously (under the skin).
  3. The vaccine, which contains weakened live viruses, is then injected.

Duration

The injection itself takes just a few seconds.

Setting

The MMRV vaccine is usually administered in a pediatrician’s office, clinic, or healthcare facility.

Personnel

  • A trained nurse or healthcare provider typically administers the vaccine.
  • A pediatrician or family doctor may also be present.

Risks and Complications

  • Common side effects include mild fever, rash, and swelling or redness at the injection site.
  • Rare but serious complications can include febrile seizures, low platelet count, or severe allergic reactions.

Benefits

  • High efficacy in preventing measles, mumps, rubella, and varicella.
  • Full immunity usually develops within a few weeks after the administration of the second dose (for children), greatly reducing the risk of contracting these diseases.

Recovery

  • Post-vaccination care includes monitoring for any adverse reactions.
  • Tylenol or ibuprofen may be recommended for pain or fever relief.
  • Most individuals can resume normal activities immediately.

Alternatives

  • Separate vaccines for measles, mumps, rubella, and varicella can be administered if the combination vaccine is not suitable.
  • Pros: Alternative schedules and flexibility.
  • Cons: More injections and healthcare visits required.

Patient Experience

  • The injection process involves minimal discomfort, akin to a small pinch.
  • Post-injection symptoms like mild soreness or fever are typically manageable with over-the-counter pain relief.
  • Comfort measures include distraction techniques for children and soothing words to reduce anxiety.

Medical Policies and Guidelines for Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use

Related policies from health plans

Similar Codes